Lung Cancer Clinical Trials

Showing 541-560 of 3,692 trials

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

NCT07308379

This is a prospective, observational, multi-center, real-world study evaluating the effectiveness and safety of Toripalimab (a PD-1 inhibitor) as first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC). The primary objective is to assess real-world progression-free survival (rwPFS). Secondary objectives include evaluating real-world objective response rate (rwORR), disease control rate (rwDCR), overall survival (rwOS), and safety. Approximately 1200 patients from multiple centers in China will be enrolled and followed according to routine clinical practice. Data will be collected from medical records and follow-up visits.

SCLC, Extensive StageToripalimab

Fudan University1,200 participantsStarted Feb 2026

RECRUITING

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

NCT05520099

The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method

ImmunotherapyCancerBladder Cancer+16 more

Elephas416 participantsStarted Jun 2023

Little Rock, Arkansas, United States • Salinas, California, United States • Orlando, Florida, United States +9 more locations

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Related Searches

Molecular Analysis of Thoracic Malignancies

Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional Methods

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2

SP Thoracic IDE Study

A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

Study Assessing QBS72S For Treating Brain Metastases

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

Testing the Engaged Approach to Lung Cancer Screening

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Benefit Evaluation of Foot Reflexology in Oncology

Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects